Life Sciences in Focus: Emerging Technologies
LSX Investor Perception Survey 2019

In this extract from the LSX Investor Perception Survey 2019, survey respondents consider the potential of emerging technologies in the healthcare industry and the factors that would increase investment in companies utilising these technologies. The 3rd annual LSX Investor Perception Survey tracks sentiment, aims, and preferences among the life science investment community. 

Download the white paper to:

  • Find out where investors see the greatest opportunities in applying advanced technologies to healthcare.
  • Discover the proportion of respondents that are already actively investing in this area or that plan to do so in the future.
  • Read commentary and insights from Helen Disney, Founder and CEO at Unblocked Events, and Jason C. Foster, Managing Director at Health Equity Consulting.

Enter your details here to receive the white paper

Formerly Known as Blog Resize

LSX (formerly Biotech and Money) is an influential community of senior life science decision makers. Through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.